Medicare Coverage: NGS Testing of Early-Stage Cancer Patients Is Back in Play

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
June 18, 2019  
placeholder COVERAGE
Medicare Coverage: NGS Testing of Early-Stage Cancer Patients Is Back in Play
From National Intelligence Report
The reimbursement outlook for those who provide next generation sequencing (NGS) testing to early-stage cancer of Medicare patients with…
Read More
placeholder TESTING STRATEGY
Rule-In Using High-Sensitivity Cardiac Troponin May Misdiagnose Heart Attacks
From Diagnostic Testing & Emerging Technologies
One in 20 patients without clinical suspicion of acute myocardial infarction has a high sensitivity cardiac troponin I (hs-cTnI) level greater than…
Read More
placeholder NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month's Key New Product Launches
From Laboratory Industry Report
Here's a summary of the key product launches from late April to late May, 2019…
Read More
placeholder MANAGING STAFF
Compliance Perspectives: How to Implement a Respiratory Protection Program at Your Lab
From Lab Compliance Advisor
Worker exposure to infection and hazardous substances is a constant and pressing challenge for lab managers. And if yours is among the many labs where workers are required…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2019, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320